See the DrugPatentWatch profile for onglyza

Based on the information available, the generic version of Onglyza (saxagliptin) has not hit the market yet. According to DrugPatentWatch.com, the patent for Onglyza is set to expire in December 2023 [1]. After a patent expires, other manufacturers can produce and sell generic versions of the drug. Therefore, it is expected that the generic version of Onglyza will become available sometime after December 2023. However, it's important to note that this timeline could be subject to change due to various factors, and it's always best to consult with a healthcare professional or pharmacist for the most up-to-date information.

Sources:
[1] <https://www.drugpatentwatch.com/drugs/onglyza>